- 专利标题： Multi-CBV vaccine for preventing or treating type I diabetes
-
申请号： US16265681申请日： 2019-02-01
-
公开(公告)号： US10780157B2公开(公告)日： 2020-09-22
- 发明人: Hyöty Heikki , Mikael Knip , Olli Laitinen , Outi Tolonen , Minna Pulkki , Sami Oikarinen , Hanna-Riikka Honkanen , Valérie Lecouturier , Jeffrey Almond , Malin Flodström-Tullberg
- 申请人： Vactech Oy
- 申请人地址： FI Tampere
- 专利权人： Vactech Oy
- 当前专利权人： Vactech Oy
- 当前专利权人地址： FI Tampere
- 代理机构： Bozicevic Field & Francis, LLP
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@73f429df
- 主分类号： A61K39/125
- IPC分类号： A61K39/125 ; A61K39/12 ; C07K16/10 ; A61K39/13 ; A61K39/39 ; A61K39/00
摘要：
The invention is directed to a vaccine comprising: i) coxsackie B virus CBV1 and CBV2, and ii) at least one coxsackie B virus selected from CBV3, CBV4, CBV5 and CBV6. The CBVs are present in the vaccine in inactivated form, in the form of a component of the virus or as an antibody against the virus. The vaccine is effective in preventing and treating type 1 diabetes. So is an anti-coxsackie B virus composition provided.
公开/授权文献
信息查询
